Arkolith/Insider Trading/RAIN/Form 4

Vellanki Avanish

Chairman and CEO, DirectorRain Oncology Inc. (RAIN) · full profile →Form 4 · filed Jan 26, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
1 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 26, 2024Tender(U)2.6M——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 26, 2024Disposed to issuer(D)30K——0
Jan 26, 2024Disposed to issuer(D)32K——0
Jan 26, 2024Disposed to issuer(D)133K——0
Jan 26, 2024Disposed to issuer(D)152K——0
Jan 26, 2024Disposed to issuer(D)14K——0
Jan 26, 2024Disposed to issuer(D)267K——0
Jan 26, 2024Disposed to issuer(D)304K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001999371-24-000956) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML